Population-Based Clinical Cancer Registration in Germany

Area of Science:

• Oncology
• Public Health
• Cancer Epidemiology

Background:

• Germany mandated expanded clinical data collection for cancer registries in 2013.
• This initiative aimed to enhance cancer care quality, transparency, and research.
• Ten years later, this study presents the current status of cancer registration in Germany.

Purpose of the Study:

• To present the current status of expanded population-based cancer registration in Germany.
• To analyze cancer incidence and survival rates using registry data.
• To evaluate the use of registry data for quality assurance and benchmarking.

Main Methods:

• Utilized data from German federal state cancer registries up to 2019.
• Calculated age-standardized incidence rates and 5-year relative survival (5YRS).
• Analyzed clinical outcomes and quality indicators (QIs) from the Cancer Registry Schleswig-Holstein (CR SH).

Main Results:

• All registries met national eligibility criteria; 505,000 cancer cases registered in 2019.
• Breast, prostate, colorectal, and lung cancers were most common; incidence slightly decreased.
• Overall 5YRS was 67% for women and 63% for men; QI differences noted among providers.

Conclusions:

• Population-based clinical cancer registration in Germany is considered successful.
• Comprehensive recording of diagnosis, treatment, and progression is established.
• Registry data are effectively used for quality assurance, benchmarking, and feedback.